Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondarily Generalized Seizures”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Post-approval studies (Phase 4)Study completedNCT03288129
What this trial is testing

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Partial Onset SeizuresSecondarily Generalized SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 54
Not applicableLooking for participantsNCT06657378
What this trial is testing

Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Who this might be right for
Partial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 110
Not applicableStudy completedNCT02722590
What this trial is testing

Fycompa (Perampanel) in Korean Participants

Who this might be right for
Epilepsy
Eisai Korea Inc. 3,692
Testing effectiveness (Phase 2)WithdrawnNCT00567424
What this trial is testing

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00236886
What this trial is testing

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Who this might be right for
EpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49
Large-scale testing (Phase 3)Study completedNCT03201900
What this trial is testing

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Who this might be right for
Partial Onset Seizures
Eisai Co., Ltd. 91
Testing effectiveness (Phase 2)Study completedNCT03754582
What this trial is testing

Intravenous Perampanel in Japanese Participants With Epilepsy

Who this might be right for
EpilepsySeizures
Eisai Co., Ltd. 21
Post-approval studies (Phase 4)Study completedNCT02726074
What this trial is testing

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
Eisai Korea Inc. 106
Testing effectiveness (Phase 2)Study completedNCT00152451
What this trial is testing

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB S.A. - Pharma Sector 31
Testing effectiveness (Phase 2)Study completedNCT00175825
What this trial is testing

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Who this might be right for
Epilepsy
UCB Pharma 210
Large-scale testing (Phase 3)Study completedNCT00367432
What this trial is testing

A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

Who this might be right for
EpilepsiesPartial
UCB Japan Co. Ltd. 398
Testing effectiveness (Phase 2)Study completedNCT00175929
What this trial is testing

Brivaracetam in Subjects With Partial Onset Seizures

Who this might be right for
Epilepsy, Focal
UCB Pharma 157
Not applicableStudy completedNCT04202159
What this trial is testing

Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures

Who this might be right for
Seizures
Eisai GmbH 187
Large-scale testing (Phase 3)Study completedNCT01228747
What this trial is testing

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Who this might be right for
EpilepsyGeneralized Tonic-Clonic Seizures
UCB Japan Co. Ltd. 361